Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia (Q36852852)

16 August 2017

1 reference

title

Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia (English)

1 reference

16 August 2017

0 references

Giovanni D'Arena

1

1 reference

PubMed ID

17577769

16 August 2017

Nicola Cascavilla

series ordinal

2

1 reference

16 August 2017

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

48

1 reference

16 August 2017

6

1 reference

16 August 2017

1072-1080

1 reference

Autoimmune complications of chronic lymphocytic leukemia

16 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity in V(H)4-34 expressing single leukemic B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

ReviewMechanisms of Immunological Tolerance Loss Versus Erythrocyte Self-antigens and Autoimmune Hemolytic Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Autoimmune pathogenesis and autoimmune hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Abnormal T-cell function in B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

B-cell chronic lymphocytic leukemia: a bird of a different feather

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Recent progress in the understanding of B-cell functions in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Syndromes of glucocorticoid resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Complications in the treatment of CLL with purine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Case/control study of the role of splenectomy in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Splenectomy in advanced chronic lymphocytic leukemia: a single institution experience with 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Use of intravenous immunoglobulin in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Control of steroid-resistant autoimmune haemolytic anaemia by cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Successful treatment of steroid-resistant hemolysis in chronic lymphocytic leukemia with cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Advances in the use of monoclonal antibodies in the therapy of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Monoclonal antibodies in the treatment of autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

A review of Campath in autoimmune disease: biologic therapy in the gray zone between immunosuppression and immunoablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

The effect of treatment with Campath-1H in patients with autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

CAMPATH-1H in the treatment of autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Intractable autoimmune hemolytic anemia in B cell chronic lymphocytic leukemia resolved by Rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Fludarabine-induced hemolytic anemia: successful treatment by rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath-1H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

Transfer of a functional human immune system to mice with severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701344923

10.1080/10428190701344923

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17577769